After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Neurogene Inc is $488.82M. A total of 1.02 million shares were traded on the day, compared to an average of 420.29K shares.
In the most recent transaction, Samsara BioCapital GP, LLC bought 48,770 shares of NGNE for 25.83 per share on Nov 26 ’24. After the transaction, the 10% Owner now owns 1,717,127 company shares. In a previous transaction on Nov 22 ’24, Cvijic Christine Mikail bought 24,000 shares at 20.48 per share. NGNE shares that President and CFO owns now total 76,844.
Among the insiders who bought shares, McMinn Rachel acquired of 47,500 shares on Nov 22 ’24 at a per-share price of $20.40. This resulted in the Chief Executive Officer holding 1,297,859 shares of NGNE after the transaction.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, NGNE has a high of $74.49 and a low of $14.42.
As of this writing, NGNE has an earnings estimate of $0 per share for the current quarter.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. NGNE’s latest balance sheet shows that the firm has $70.54M in Cash & Short Term Investments as of fiscal 2021. There were $5.21M in debt and $10.86M in liabilities at the time. Its Book Value Per Share was $10.56, while its Total Shareholder’s Equity was -$91.88M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NGNE is Buy with a score of 5.00.
